Atlas Trials

A Study to Assess the Safety, Tolerability, Effectiveness and Absorption of Exodif™ Tablets in Clostridium Difficile-associated Diarrhea

Clinical trial NCT00466635 · TERMINATED

Trial details

NCT number
NCT00466635
Sponsor
Genzyme, a Sanofi Company
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Enterocolitis, PseudomembranousDiarrheaClostridium Difficile
Start date
2007-04-01
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.